Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("BROMPERIDOL")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 55

  • Page / 3

Export

Selection :

  • and

INTERNATIONAL SYMPOSIUM ON BROMPERIDOL; BRUGES; 1977.1978; ACTA PSYCHIATR. BELG.; BELG.; DA. 1978; VOL. 78; NO 1; PP. 3-211; ABS. FR. NEERL. ALLEM. ITAL. ESP. RUSSE; BIBL. DISSEM.Conference Paper

Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients : A preliminary studyYASUI-FURUKORI, Norio; SAITO, Manabu; NAKAGAMI, Taku et al.Progress in neuro-psychopharmacology & biological psychiatry. 2006, Vol 30, Num 2, pp 286-291, issn 0278-5846, 6 p.Article

Possible interaction between cisapride and bromperidolISHIDA, M; OTANI, K; YASUI, N et al.Progress in neuro-psychopharmacology & biological psychiatry. 1997, Vol 21, Num 1, pp 235-238, issn 0278-5846Article

TOXIKOLOGISCHE, ENDOKRINOLOGISCHE UND KLINISCHE ASPEKTE BEI DER PRUEFUNG EINES NEUEN NEUROLEPTIKUMS (BROMPERIDOL): WISSENSCHAFTLICHES GESFNAECH ANLAESSLICH DES SYMPOSIUMS UEBER BROMPERIDOL, ZUERICH, 26-27 NOVEMBER 1976 = ASPECTS TOXICOLOGIQUES, ENDOCRINOLOGIQUES, ET CLINIQUES LORS DE L'ESSAI D'UN NOUVEAU NEUROLEPTIQUE: BROMPERIDOL. PRESENTATION DU SYMPOSIUM SUR LE BROMPERIDOL: ZUERICH 26-27 NOVEMBRE 19761978; INTERNATION. PHARMACOPSYCHIATRY; CHE; DA. 1978; VOL. 13; SUPPL. 1; 94 P.; BIBL. DISSEM.Article

Role of CYP3A in bromperidol metabolism in rat in vitro and in vivoWATANABE, M; TATEISHI, T; TANAKA, M et al.Xenobiotica (London. Print). 1999, Vol 29, Num 8, pp 839-846, issn 0049-8254Article

Prolactin response to bromperidol treatment in schizophrenic patientsYASUI, N; KONDO, T; OTANI, K et al.Pharmacology & toxicology. 1998, Vol 82, Num 3, pp 153-156, issn 0901-9928Article

Correlation between steady-state plasma concentrations (Css) of bromperidol and haloperidolYASUI, N; OTANI, K; KONDO, T et al.Progress in neuro-psychopharmacology & biological psychiatry. 1998, Vol 22, Num 3, pp 485-492, issn 0278-5846Article

Analyses of butyrophenones and their analogues in whole blood by high-performance liquid chromatography-electrospray tandem mass spectrometrySENO, Hiroshi; HATTORI, Hideki; ISHII, Akira et al.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 746, Num 1, pp 3-9, issn 1387-2273Article

Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metaboliteSUZUKI, A; OTANI, K; MIHARA, K et al.Psychopharmacologia. 1998, Vol 135, Num 4, pp 333-337, issn 0033-3158Article

DER EINFLUSS VON DIAGNOSE, KLINIK UND GESCHLECHT AUF DIE WIRKUNG VON BROMPERIDOL = INFLUENCE DU DIAGNOSTIC DE LA CLINIQUE ET DU SEXE SUR L'ACTIVITE DU BROMPERIDOLWOGGON B; FLEISCHHAUER J; WIDMER A et al.1979; INTERNATION. PHARMACOPSYCHIATRY; CHE; DA. 1979; VOL. 14; NO 4; PP. 213-227; ABS. ENG; BIBL. 22 REF.Article

Comparison of prolactin concentrations between haloperidol and bromperidol treatments in schizophrenic patientsYASUI-FURUKORI, Norio; KONDO, Tsuyoshi; SUZUKI, Akihito et al.Progress in neuro-psychopharmacology & biological psychiatry. 2002, Vol 26, Num 3, pp 575-578, issn 0278-5846Article

Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidolMIHARA, Kazuo; SUZUKI, Akihito; KONDO, Tsuyoshi et al.American journal of medical genetics. 2001, Vol 105, Num 3, pp 271-274, issn 0148-7299Conference Paper

No Pharmacokinetic but pharmacodynamic interactions between cisapride and bromperidol or haloperidolMIHARA, K; OTANI, K; YASUI, N et al.Therapeutic drug monitoring. 1999, Vol 21, Num 3, pp 297-300, issn 0163-4356Article

Poor reliability of therapeutic drug monitoring data for haloperidol and bromperidol using enzyme immunoassayYASUI-FURUKORI, Norio; FURUKORI, Hanako; SAITO, Manabu et al.Therapeutic drug monitoring. 2003, Vol 25, Num 6, pp 709-714, issn 0163-4356, 6 p.Article

Involvement of CYP3A4 in the metabolism of bromperidol in vitroSATO, S; SOMEYA, T; SHIOIRI, T et al.Pharmacology & toxicology. 2000, Vol 86, Num 3, pp 145-148, issn 0901-9928Article

Systematic meta-review of depot antipsychotic drugs for people with schizophreniaADAMS, Clive E; FENTON, Mark K. P; QURAISHI, Seema et al.British journal of psychiatry (Print). 2001, Vol 179, Num OCT, pp 290-299, issn 0007-1250Article

Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazineSUZUKI, A; OTANI, K; ISHIDA, M et al.Therapeutic drug monitoring. 1997, Vol 19, Num 3, pp 261-264, issn 0163-4356Article

Interaction between carbamazepine and bromperidolOTANI, K; ISHIDA, M; YASUI, N et al.European journal of clinical pharmacology. 1997, Vol 52, Num 3, pp 219-222, issn 0031-6970Article

No interaction between desipramine and bromperidolSUZUKI, A; OTANI, K; ISHIDA, M et al.Progress in neuro-psychopharmacology & biological psychiatry. 1996, Vol 20, Num 7, pp 1265-1271, issn 0278-5846Article

Therapeutic effects of bromperidol on the five dimensions of schizophrenic symptomsYASUI-FURUKORI, Norio; KONDO, Tsuyoshi; ISHIDA, Masayuki et al.Progress in neuro-psychopharmacology & biological psychiatry. 2002, Vol 26, Num 1, pp 53-57, issn 0278-5846Article

Simultaneous Determination of N-Dealkylated Metabolites of Four Butyrophenone-Type Agents by HPLC with Fluorescence Detection after Pre-Column Derivatization with Dansyl ChlorideHIGASHI, Yasuhiko; SAKATA, Masatoshi; NAKAMURA, Shota et al.Journal of liquid chromatography & related technologies. 2008, Vol 31, Num 17-20, pp 2762-2770, issn 1082-6076, 9 p.Article

BROMPERIDOL MAINTENANCE IN SCHIZOPHRENIAMCEVOY JP; WILSON WH; BAN TA et al.1982; PHARMACOPSYCHIATRIA; ISSN 0720-4280; DEU; DA. 1982; VOL. 15; NO 3; PP. 95-96; ABS. GER; BIBL. 6 REF.Article

Comparison of the anti-dopamine D2 and anti-serotonin 5-HT2A activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereofSUZUKI, Hidenobu; GEN, Keishi; INOUE, Yuichi et al.Journal of psychopharmacology (Oxford). 2013, Vol 27, Num 4, pp 396-400, issn 0269-8811, 5 p.Article

Simultaneous determination of four basic metabolites formed from butyrophenone type agents by HPLC with dual ultraviolet detectionHIGASHI, Yasuhiko; SAKATA, Masatoshi; FUJII, Youichi et al.Journal of liquid chromatography & related technologies. 2006, Vol 29, Num 17-20, pp 2853-2862, issn 1082-6076, 10 p.Article

No relationship between - 141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary studyMIHARA, Kazuo; KONDO, Tsuyoshi; SUZUKI, Akihito et al.Psychiatry research. 2001, Vol 101, Num 1, pp 33-38, issn 0165-1781Article

  • Page / 3